http://www.oteurope.com/ophthalmologytimeseurope/Ophthalmology+research+news/Article/list/43273 Latest ophthalmic research news. 2013-06-20T11:12:44Z http://www.oteurope.com/ophthalmologytimeseurope/Latest+News/Safety-first-pIOL-is-effective-for-myopic-astigmat/ArticleStandard/Article/detail/781035?contextCategoryId=43273&ref=25 Implantation of the Artiflex toric iris-fixated phakic IOL is effective, predictable and safe for the correction of myopic astigmatism. 2012-07-16T04:00:00Z http://www.oteurope.com/ophthalmologytimeseurope/data/articlestandard/ophthalmologytimeseurope/282012/781035null HTML http://www.oteurope.com/ophthalmologytimeseurope/Cornea/Inhibiting-and-regressing-corneal-neovascularisati/ArticleStandard/Article/detail/625485?contextCategoryId=43273&ref=25 Interim results from a Phase II study by Gene Signal suggest that antisense oligonucleotide GS-101 is safe and effective at inhibiting abnormal corneal new blood vessel growth. 2009-09-11T04:00:00Z http://www.oteurope.com/ophthalmologytimeseurope/data/articlestandard/ophthalmologytimeseurope/372009/625485null HTML http://www.oteurope.com/ophthalmologytimeseurope/Glaucoma+news/Glaucoma-related-to-selenium-levels/ArticleStandard/Article/detail/622245?contextCategoryId=43273&ref=25 The pathology of glaucoma is likely to be related to the presence and levels of selenium, according to the results of a study published in the August issue of the British Journal of Ophthalmology. 2009-09-02T04:00:00Z http://www.oteurope.com/ophthalmologytimeseurope/data/articlestandard/ophthalmologytimeseurope/352009/622245null HTML http://www.oteurope.com/ophthalmologytimeseurope/Latest+News/The-brain-predicts-what-moving-eyes-will-see/ArticleStandard/Article/detail/622247?contextCategoryId=43273&ref=25 A new study conducted by researchers at the University of Aberdeen, Scotland, has found that the brain predicts the consequences of eye movement even before the eyes take in a new scene. 2009-09-02T04:00:00Z http://www.oteurope.com/ophthalmologytimeseurope/data/articlestandard/ophthalmologytimeseurope/352009/622247null HTML http://www.oteurope.com/ophthalmologytimeseurope/Latest+News/Lowering-levels-of-arginase-may-halt-progression-o/ArticleStandard/Article/detail/622249?contextCategoryId=43273&ref=25 High levels of the enzyme arginase contributes to vascular eye damage, and therapies to lower its levels could halt progression of diabetic retinopathy (DR), according to researchers at the Medical College of Georgia (MCG) School of Medicine, USA. 2009-09-02T04:00:00Z http://www.oteurope.com/ophthalmologytimeseurope/data/articlestandard/ophthalmologytimeseurope/352009/622249null HTML http://www.oteurope.com/ophthalmologytimeseurope/Latest+News/When-can-an-eye-growth-transform-into-melanoma/ArticleStandard/Article/detail/619343?contextCategoryId=43273&ref=25 According to a report in the August issue of Archives of Ophthalmology, there are eight factors that may predict whether a choroidal nevus-a benign, flat, pigmented growth inside the eye and beneath the retina-may develop into melanoma. 2009-08-19T04:00:00Z http://www.oteurope.com/ophthalmologytimeseurope/data/articlestandard/ophthalmologytimeseurope/342009/619343null HTML http://www.oteurope.com/ophthalmologytimeseurope/Latest+News/Gene-therapy-delivers-bonus-results/ArticleStandard/Article/detail/619317?contextCategoryId=43273&ref=25 Partial sections of vision were recently restored to a blind woman's retina through the use of gene therapy. 2009-08-19T04:00:00Z http://www.oteurope.com/ophthalmologytimeseurope/data/articlestandard/ophthalmologytimeseurope/342009/619317null HTML http://www.oteurope.com/ophthalmologytimeseurope/CatRef+news/Researchers-uncover-genetic-link-to-age-related-ca/ArticleStandard/Article/detail/619345?contextCategoryId=43273&ref=25 Researchers in Cleveland have discovered the first gene associated with the formation of age-related cataracts. EphA2 encodes an enzyme that plays a role in the repair of proteins in the lens of the eye after they become damaged and clump together, according to the investigators. 2009-08-19T04:00:00Z http://www.oteurope.com/ophthalmologytimeseurope/data/articlestandard/ophthalmologytimeseurope/342009/619345null HTML http://www.oteurope.com/ophthalmologytimeseurope/Glaucoma+news/Implant-with-potential-to-permanently-treat-glauco/ArticleStandard/Article/detail/619318?contextCategoryId=43273&ref=25 OcumatRx, an early stage company that is developing a medical device that represents a new concept for the permanent treatment of patients with glaucoma, has announced the successful completion of clinical trials for their first device with favourable preliminary safety and tolerability. 2009-08-19T04:00:00Z http://www.oteurope.com/ophthalmologytimeseurope/data/articlestandard/ophthalmologytimeseurope/342009/619318null HTML http://www.oteurope.com/ophthalmologytimeseurope/CatRef+news/Clinical-trials-show-promise-to-help-mydriasis-dur/ArticleStandard/Article/detail/619319?contextCategoryId=43273&ref=25 Results from the Omeros Corporation for the Phase I/Phase II clinical trial of OMS302, a proprietary combination of an anti-inflammatory agent and an agent that causes pupil dilation (mydriasis) are said to be promising. 2009-08-19T04:00:00Z http://www.oteurope.com/ophthalmologytimeseurope/data/articlestandard/ophthalmologytimeseurope/342009/619319null HTML http://www.oteurope.com/ophthalmologytimeseurope/Dry+Eye/Severe-trachomatous-dry-eye-treatment/ArticleStandard/Article/detail/615861?contextCategoryId=43273&ref=25 Dr Mustafa Guzey and colleagues have found topical cyclosporine A to be effective in treating severe trachomatous dry eye in a recent study published in Clinical & Experimental Ophthalmology. 2009-08-05T04:00:00Z http://www.oteurope.com/ophthalmologytimeseurope/data/articlestandard/ophthalmologytimeseurope/322009/615861null HTML http://www.oteurope.com/ophthalmologytimeseurope/Latest+News/New-treatment-succeeds-after-laser-fails-in-diabet/ArticleStandard/Article/detail/615858?contextCategoryId=43273&ref=25 This month's Ophthalmology, the journal of the American Academy of Ophthalmology, reports on use of bevacizumab (Avastin), to benefit diabetic patients with macular oedema as well as people who develop cystoid macular oedema after cataract surgery. 2009-08-05T04:00:00Z http://www.oteurope.com/ophthalmologytimeseurope/data/articlestandard/ophthalmologytimeseurope/322009/615858null HTML http://www.oteurope.com/ophthalmologytimeseurope/Latest+News/A-clinical-conundrum/ArticleStandard/Article/detail/615857?contextCategoryId=43273&ref=25 According to the J Pediatr Ophthalmol Strabismus 2009;46:238-240 optic disc oedema is a clinical conundrum which has potential to delay diagnosis and therefore treatment of idiopathic intracranial hypertension. 2009-08-05T04:00:00Z http://www.oteurope.com/ophthalmologytimeseurope/data/articlestandard/ophthalmologytimeseurope/322009/615857null HTML http://www.oteurope.com/ophthalmologytimeseurope/CatRef+news/Light-adjustable-lenses-offer-stability-of-refract/ArticleStandard/Article/detail/612231?contextCategoryId=43273&ref=25 Residual myopic errors can be successfully corrected postoperatively by using light-adjustable lens technology (LAL) in cataract patients, concludes a study published online by Ophthalmology. 2009-07-22T04:00:00Z http://www.oteurope.com/ophthalmologytimeseurope/data/articlestandard/ophthalmologytimeseurope/302009/612231null HTML http://www.oteurope.com/ophthalmologytimeseurope/Glaucoma+news/A-comparison-of-ELT-and-SLT/ArticleStandard/Article/detail/612228?contextCategoryId=43273&ref=25 A study by Italian researchers, the results of which have been published online by Eye, has found that both excimer laser trabeculotomy (ELT) and selective laser trabeculoplasty (SLT) are both equally effective treatment options for primary open angle glaucoma. 2009-07-22T04:00:00Z http://www.oteurope.com/ophthalmologytimeseurope/data/articlestandard/ophthalmologytimeseurope/302009/612228null HTML http://www.oteurope.com/ophthalmologytimeseurope/AMD+news/Early-AMD-associated-with-coronary-heart-disease/ArticleStandard/Article/detail/612229?contextCategoryId=43273&ref=25 The results of a study published in the July issue of Ophthalmology has discovered that people in the early stages of age-related macular degeneration (AMD) are at a higher risk of developing coronary heart disease (CHD), offering further support to the theory that AMD is associated with underlying systemic vascular disease. 2009-07-22T04:00:00Z http://www.oteurope.com/ophthalmologytimeseurope/data/articlestandard/ophthalmologytimeseurope/302009/612229null HTML http://www.oteurope.com/ophthalmologytimeseurope/Latest+News/ICLs-effective-over-long-periods/ArticleStandard/Article/detail/612230?contextCategoryId=43273&ref=25 The use of implantable collamer lenses (ICLs) to correct moderate to high myopia can offer predictable and stable results over a long period of time, according to a report published in the July issue of Archives of Ophthalmology. 2009-07-22T04:00:00Z http://www.oteurope.com/ophthalmologytimeseurope/data/articlestandard/ophthalmologytimeseurope/302009/612230null HTML http://www.oteurope.com/ophthalmologytimeseurope/Latest+News/Clinical-improvement-in-adenoviral-conjunctivitis-/ArticleStandard/Article/detail/610492?contextCategoryId=43273&ref=25 Foresight Biotherapeutics, Inc. has announced data from a pre-clinical study designed to assess the safety and efficacy of the topical administration of FST-100 in a highly regarded Ad5 NZW rabbit model of adenoviral conjunctivitis. 2009-07-15T04:00:00Z http://www.oteurope.com/ophthalmologytimeseurope/data/articlestandard/ophthalmologytimeseurope/292009/610492null HTML http://www.oteurope.com/ophthalmologytimeseurope/Latest+News/New-technique-will-help-retinitis-pigmentosa-study/ArticleStandard/Article/detail/610495?contextCategoryId=43273&ref=25 Spanish researchers have used the induction of neuronal degeneration of intense light exposure in mice retina in an experimental model of retinitis pigmentosa. 2009-07-15T04:00:00Z http://www.oteurope.com/ophthalmologytimeseurope/data/articlestandard/ophthalmologytimeseurope/292009/610495null HTML http://www.oteurope.com/ophthalmologytimeseurope/AMD+news/AMD-prediction-a-step-closer-using-nature-or-nutur/ArticleStandard/Article/detail/610488?contextCategoryId=43273&ref=25 Prevalence and incidence of advanced AMD can be catergorized as 'nature' or 'nurture' using a prediction model, based on genetic, environmental and demographic variables. 2009-07-15T04:00:00Z http://www.oteurope.com/ophthalmologytimeseurope/data/articlestandard/ophthalmologytimeseurope/292009/610488null HTML http://www.oteurope.com/ophthalmologytimeseurope/Latest+News/Microplasmin-may-eliminate-need-for-surgery/ArticleStandard/Article/detail/610493?contextCategoryId=43273&ref=25 Microplasmin, the drug aimed at patients with focal vitreomacular adhesion, is to be trialled at Southampton General Hospital. Injected directly into the eye earlier clinical studies have indicated that it has potential to be effective without the risks associated with surgery. 2009-07-15T04:00:00Z http://www.oteurope.com/ophthalmologytimeseurope/data/articlestandard/ophthalmologytimeseurope/292009/610493null HTML http://www.oteurope.com/ophthalmologytimeseurope/Cornea/Future-of-corneal-tomography/ArticleStandard/Article/detail/610584?contextCategoryId=43273&ref=25 CSO, which has a background in measuring and analysing the anterior corneal surface has extended its research to the posterior surface with its new device SIRIUS. 2009-07-15T04:00:00Z http://www.oteurope.com/ophthalmologytimeseurope/data/articlestandard/ophthalmologytimeseurope/292009/610584null HTML http://www.oteurope.com/ophthalmologytimeseurope/Retina+news/RP-modulation-with-stem-cells/ArticleStandard/Article/detail/608782?contextCategoryId=43273&ref=25 Stemedica Cell Technologies, Inc., (Stemedica),a manufacturer and developer of clinical grade allogeneic adult stem cell technology, has discovered a significant breakthrough in the use of human stem cells and stem cell factors for the potential treatment of degenerations of the retina and retinal pigmented epithelium. 2009-07-08T04:00:00Z http://www.oteurope.com/ophthalmologytimeseurope/data/articlestandard/ophthalmologytimeseurope/282009/608782null HTML http://www.oteurope.com/ophthalmologytimeseurope/CatRef+news/Phacoemulsification-fluidics-characterized-by-new-/ArticleStandard/Article/detail/608780?contextCategoryId=43273&ref=25 Implementation of novel techniques to analyze the fluidic signature of phacoemulsification performed using different ultrasound modalities and phaco tips is providing important insights that will be helpful for improving the efficiency and safety of lens removal surgery. 2009-07-08T04:00:00Z http://www.oteurope.com/ophthalmologytimeseurope/data/articlestandard/ophthalmologytimeseurope/282009/608780null HTML http://www.oteurope.com/ophthalmologytimeseurope/Latest+News/Parasitic-eye-infections-tied-to-contact-lens-solu/ArticleStandard/Article/detail/608779?contextCategoryId=43273&ref=25 An inspection conducted by the US Food and Drug Administration determined that a subsidiary of Abbott Park, Ill.-based Abbott Laboratories Inc. failed to disclose multiple reports of a serious parasitic eye infection for more than a year. 2009-07-08T04:00:00Z http://www.oteurope.com/ophthalmologytimeseurope/data/articlestandard/ophthalmologytimeseurope/282009/608779null HTML http://www.oteurope.com/ophthalmologytimeseurope/Glaucoma+news/Glaucoma-and-blocked-blood-vessels/ArticleStandard/Article/detail/608777?contextCategoryId=43273&ref=25 A study reported in the July issue of Ophthalmology, the journal of the American Academy of Ophthalmology correlates the incidence of silent cerebral infarcts (SCI) and visual field loss in patients with normal-tension glaucoma. 2009-07-08T04:00:00Z http://www.oteurope.com/ophthalmologytimeseurope/data/articlestandard/ophthalmologytimeseurope/282009/608777null HTML http://www.oteurope.com/ophthalmologytimeseurope/Cornea/Inflammation-thwarts-corneal-transplants-in-herpes/ArticleStandard/Article/detail/608778?contextCategoryId=43273&ref=25 A further study in the July issue of Ophthalmology, the journal of the American Academy of Ophthalmology, investigated inflammation biomarkers in relation to corneal transplant rejection in herpes simplex patients. Its results have shown that inflammation thwarts corneal transplants. 2009-07-08T04:00:00Z http://www.oteurope.com/ophthalmologytimeseurope/data/articlestandard/ophthalmologytimeseurope/282009/608778null HTML http://www.oteurope.com/ophthalmologytimeseurope/Dry+Eye/Regimen-change-cuts-eye-drops-use-in-half/ArticleStandard/Article/detail/605267?contextCategoryId=43273&ref=25 Nerve damage associated ocular dryness improved dramatically with hyaluronic acid-based lubricating eye drops explains Claes Feinbaum M.Sc. Professor Emeritus Optometry, Vision4You, Lund, Sweden. 2009-06-24T04:00:00Z http://www.oteurope.com/ophthalmologytimeseurope/data/articlestandard/ophthalmologytimeseurope/262009/605267null HTML http://www.oteurope.com/ophthalmologytimeseurope/Dry+Eye/High-viscosity-eye-drop-improves-T-BUT-in-VDT-user/ArticleStandard/Article/detail/605270?contextCategoryId=43273&ref=25 High molecular weight increases blink rate and helps eye drops retain moisture on the ocular surface according to Professor Giancarlo Montani an optometrist FIACLE and a professor of optometry at the Universita del Salento in Italy. 2009-06-24T04:00:00Z http://www.oteurope.com/ophthalmologytimeseurope/data/articlestandard/ophthalmologytimeseurope/262009/605270null HTML http://www.oteurope.com/ophthalmologytimeseurope/Glaucoma+news/Gene-therapies/ArticleStandard/Article/detail/605269?contextCategoryId=43273&ref=25 Ocular applications of gene therapies are increasing, as is our understanding of the molecular pathogenesis of glaucoma. 2009-06-24T04:00:00Z http://www.oteurope.com/ophthalmologytimeseurope/data/articlestandard/ophthalmologytimeseurope/262009/605269null HTML http://www.oteurope.com/ophthalmologytimeseurope/AMD+news/Question-mark-over-Novartis-combination-therapy/ArticleStandard/Article/detail/603602?contextCategoryId=43273&ref=25 The twelve-month primary analysis results from the Novartis sponsored Phase II MONT BLANC study investigating the efficacy and safety of combining Visudyne (Novartis Pharma AG) and Lucentis (Novartis Pharma AG, Genentech Inc.) have been released and so far are showing no significant differences. 2009-06-17T04:00:00Z http://www.oteurope.com/ophthalmologytimeseurope/data/articlestandard/ophthalmologytimeseurope/252009/603602null HTML http://www.oteurope.com/ophthalmologytimeseurope/Cornea/3D-corneal-construction-using-stem-cells/ArticleStandard/Article/detail/603596?contextCategoryId=43273&ref=25 Producing 3D human corneal tissue using corneal limbal stem cells with a view to developing and commercialising novel technology has potential to transform drug discovery and regenerative medicine. 2009-06-17T04:00:00Z http://www.oteurope.com/ophthalmologytimeseurope/data/articlestandard/ophthalmologytimeseurope/252009/603596null HTML http://www.oteurope.com/ophthalmologytimeseurope/AMD+news/AMD-biological-marker-discovered/ArticleStandard/Article/detail/603606?contextCategoryId=43273&ref=25 A biological marker for neovascular age-related macular degeneration (AMD) has been discovered by a team of researchers from the University of Kentucky. 2009-06-17T04:00:00Z http://www.oteurope.com/ophthalmologytimeseurope/data/articlestandard/ophthalmologytimeseurope/252009/603606null HTML http://www.oteurope.com/ophthalmologytimeseurope/Latest+News/Dr-Ambati-wins-2010-ARVO-award/ArticleStandard/Article/detail/603598?contextCategoryId=43273&ref=25 Dr Jayakrishna Ambati, professor and vice chairman of Ophthalmology and Visual Sciences at the University of Kentucky, has been chosen to receive the 2010 Cogan Award from The Association for Research in Vision and Opthalmology (ARVO). 2009-06-17T04:00:00Z http://www.oteurope.com/ophthalmologytimeseurope/data/articlestandard/ophthalmologytimeseurope/252009/603598null HTML http://www.oteurope.com/ophthalmologytimeseurope/Cornea/Cornea-breakthrough/ArticleStandard/Article/detail/600874?contextCategoryId=43273&ref=25 Harvested stem cells from patients' own eyes to rehabilitate damaged cornea in just ten days may prove to be a world-first breakthrough in restoring sight. 2009-06-03T04:00:00Z http://www.oteurope.com/ophthalmologytimeseurope/data/articlestandard/ophthalmologytimeseurope/232009/600874null HTML http://www.oteurope.com/ophthalmologytimeseurope/Latest+News/Stem-cells-may-restore-retinal-tissue-damage/ArticleStandard/Article/detail/600873?contextCategoryId=43273&ref=25 Stem cells, extracted from bone marrow can restore damaged retinal tissue through new cell generation, according to a recent discovery by researchers at the University of Louisville. 2009-06-03T04:00:00Z http://www.oteurope.com/ophthalmologytimeseurope/data/articlestandard/ophthalmologytimeseurope/232009/600873null HTML http://www.oteurope.com/ophthalmologytimeseurope/Latest+News/Few-genetic-changes-profoundly-alter-eye-anatomy/ArticleStandard/Article/detail/599409?contextCategoryId=43273&ref=25 Researchers comparing the fetal development of the eye of the owl monkey with that of the capuchin monkey have found that only a minor difference in the timing of cell proliferation can explain the multiple anatomical differences in the two kinds of eyes. 2009-05-27T04:00:00Z http://www.oteurope.com/ophthalmologytimeseurope/data/articlestandard/ophthalmologytimeseurope/212009/599409null HTML http://www.oteurope.com/ophthalmologytimeseurope/Latest+News/DR-and-sleep-apnoea-linked/ArticleStandard/Article/detail/599407?contextCategoryId=43273&ref=25 New research indicates that patients with diabetic retinopathy (DR) should also be screened for obstructive sleep apnoea (OSA). 2009-05-27T04:00:00Z http://www.oteurope.com/ophthalmologytimeseurope/data/articlestandard/ophthalmologytimeseurope/212009/599407null HTML http://www.oteurope.com/ophthalmologytimeseurope/Latest+News/Activity-update-on-therapeutics/ArticleStandard/Article/detail/599413?contextCategoryId=43273&ref=25 The increased activity in ophthalmic research is reflected in the long list of clinical studies in their various stages: nearly 300 studies of various aspects of glaucoma and close to 250 studies on ocular surface, cornea and dry eye. 2009-05-27T04:00:00Z http://www.oteurope.com/ophthalmologytimeseurope/data/articlestandard/ophthalmologytimeseurope/212009/599413null HTML http://www.oteurope.com/ophthalmologytimeseurope/Latest+News/Tamsulosin-and-cataract-surgery-complications/ArticleStandard/Article/detail/599406?contextCategoryId=43273&ref=25 According to a report in the Journal of the American Medical Association patients taking tamsulosin for benign prostrate enlargement within 14 days of cataract surgery may have an increased risk of complications. 2009-05-27T04:00:00Z http://www.oteurope.com/ophthalmologytimeseurope/data/articlestandard/ophthalmologytimeseurope/212009/599406null HTML http://www.oteurope.com/ophthalmologytimeseurope/Glaucoma+news/Catioprost-gets-the-go-ahead-for-Phase-III-trial/ArticleStandard/Article/detail/597504?contextCategoryId=43273&ref=25 Novagali Pharma, the French pharmaceutical ophthalmic company, is to conduct a Phase III clinical trial of Catioprost (Nova21027) its Investigational New Drug Application (IND). 2009-05-13T04:00:00Z http://www.oteurope.com/ophthalmologytimeseurope/data/articlestandard/ophthalmologytimeseurope/202009/597504null HTML http://www.oteurope.com/ophthalmologytimeseurope/Ophthalmology+product+news/Predicting-diabetic-retinopathy-progression/ArticleStandard/Article/detail/597505?contextCategoryId=43273&ref=25 A diabetic retinopathy (DR) progression biomarker software has been developed with the research institute AIBILI (Association for Biomedical Research and Innovation in Light and Image) and Critical Health. 2009-05-13T04:00:00Z http://www.oteurope.com/ophthalmologytimeseurope/data/articlestandard/ophthalmologytimeseurope/202009/597505null HTML http://www.oteurope.com/ophthalmologytimeseurope/Glaucoma+news/Canaloplasty-2-year-clinical-results-published/ArticleStandard/Article/detail/597502?contextCategoryId=43273&ref=25 Results of the evaluation of two-year post-surgical safety and efficacy of canaloplasty to treat open angle glaucoma (OAG) have been published in the Journal of Cataract and Refractive Surgery. Dr Richard A Lewis et al., concluded that the procedure was safe and effective in reducing IOP in adult OAG patients. 2009-05-13T04:00:00Z http://www.oteurope.com/ophthalmologytimeseurope/data/articlestandard/ophthalmologytimeseurope/202009/597502null HTML http://www.oteurope.com/ophthalmologytimeseurope/Cornea/Worlds-largest-eye-bank-launches-research-institut/ArticleStandard/Article/detail/597508?contextCategoryId=43273&ref=25 The world's largest eye bank, The Tampa Lions Eye Institute for Transplant and Research, Inc. in Florida, which has supplied over 30,000 corneas for transplant and 50,000 eyes for research worldwide over the past 30 years, is to open a state-of-the-art research facility. 2009-05-13T04:00:00Z http://www.oteurope.com/ophthalmologytimeseurope/data/articlestandard/ophthalmologytimeseurope/202009/597508null HTML http://www.oteurope.com/ophthalmologytimeseurope/AMD+news/Fenretinide-Phase-II-trials-results-imminent/ArticleStandard/Article/detail/594146?contextCategoryId=43273&ref=25 Interim analysis of Phase II trials for fenretinide and its use in the treatment of geographic atrophy (GA) are looking positive, according to Sirion Therapeutics, Inc. 2009-04-22T04:00:00Z http://www.oteurope.com/ophthalmologytimeseurope/data/articlestandard/ophthalmologytimeseurope/172009/594146null HTML http://www.oteurope.com/ophthalmologytimeseurope/Latest+News/Not-a-dry-eye-in-the-house/ArticleStandard/Article/detail/594145?contextCategoryId=43273&ref=25 Significant improvement in signs and symptoms in patients suffering from moderate-to-severe dry eye syndrome have been found following the Phase II trial of Cyclokat, the formulation of cyclosporine by French pharmaceutical ophthalmic company Novagali Pharma. 2009-04-22T04:00:00Z http://www.oteurope.com/ophthalmologytimeseurope/data/articlestandard/ophthalmologytimeseurope/172009/594145null HTML http://www.oteurope.com/ophthalmologytimeseurope/Latest+News/Retina-is-a-multi-layered-jigsaw-of-receptive-fiel/ArticleStandard/Article/detail/592547?contextCategoryId=43273&ref=25 1.25 million neurons view the world through receptive fields, which operate like a multi-layered jigsaw puzzle. Researchers at the Salk Institute for Biological Studies imply that the nervous system operates with higher precision than previously appreciated, and that apparent irregularities in individual cells may actually be coordinated and more finely tuned. 2009-04-15T04:00:00Z http://www.oteurope.com/ophthalmologytimeseurope/data/articlestandard/ophthalmologytimeseurope/152009/592547null HTML http://www.oteurope.com/ophthalmologytimeseurope/Latest+News/TGF-beta-has-essential-role-in-retinal-health/ArticleStandard/Article/detail/592550?contextCategoryId=43273&ref=25 The Schepens Eye Research Institute has found that retinal dysfunction may be caused by blocking the growth factor TGF-beta. The research may have an important impact on the prevention and treatment of diabetic retinopathy and macular degeneration. 2009-04-15T04:00:00Z http://www.oteurope.com/ophthalmologytimeseurope/data/articlestandard/ophthalmologytimeseurope/152009/592550null HTML http://www.oteurope.com/ophthalmologytimeseurope/Latest+News/Warning-to-ophthalmologists/ArticleStandard/Article/detail/592546?contextCategoryId=43273&ref=25 "When treating patients with DME, ophthalmologists should consider the role of the glitazone class of drugs," warn the authors of a study published in the April issue of the American Journal of Ophthalmology. 2009-04-15T04:00:00Z http://www.oteurope.com/ophthalmologytimeseurope/data/articlestandard/ophthalmologytimeseurope/152009/592546null HTML http://www.oteurope.com/ophthalmologytimeseurope/Cornea/Surgical-first-for-ocular-bandage/ArticleStandard/Article/detail/592549?contextCategoryId=43273&ref=25 The first ophthalmic surgery in Europe using the CE mark approved I-SIPxAE Adherent Ocular Bandage was conducted in the UK by Dr Daniel Calladine and Mr Richard Packard. 2009-04-15T04:00:00Z http://www.oteurope.com/ophthalmologytimeseurope/data/articlestandard/ophthalmologytimeseurope/152009/592549null HTML http://www.oteurope.com/ophthalmologytimeseurope/Latest+News/Gene-silencing-may-help-corneal-transplantation/ArticleStandard/Article/detail/592545?contextCategoryId=43273&ref=25 The side effects of an experimental 'gene-silencing' treatment that is currently being investigated for a variety of diseases could be useful in corneal transplantation, where growth of new blood and lymph vessels is believed to be a major cause of graft failure. 2009-04-15T04:00:00Z http://www.oteurope.com/ophthalmologytimeseurope/data/articlestandard/ophthalmologytimeseurope/152009/592545null HTML http://www.oteurope.com/ophthalmologytimeseurope/Latest+News/Eye-diseases-in-pre-school-children-more-common-th/ArticleStandard/Article/detail/591769?contextCategoryId=43273&ref=25 In what is believed to be the first comprehensive eye disease study among urban pre-schoolers, investigators writing in the April issue of the journal Ophthalmology report that while vision problems are rare, they are more common than once thought. 2009-04-08T04:00:00Z http://www.oteurope.com/ophthalmologytimeseurope/data/articlestandard/ophthalmologytimeseurope/152009/591769null HTML http://www.oteurope.com/ophthalmologytimeseurope/Latest+News/First-molecular-map-of-the-entire-retina-is-not-fa/ArticleStandard/Article/detail/591771?contextCategoryId=43273&ref=25 Researchers at the Moran Eye Centre are using transmission electron microscopes (TEMs) to develop TEM-compatible molecular probes with software that will tag cells with a molecular signature, creating 'colour' TEM imaging. 2009-04-08T04:00:00Z http://www.oteurope.com/ophthalmologytimeseurope/data/articlestandard/ophthalmologytimeseurope/152009/591771null HTML http://www.oteurope.com/ophthalmologytimeseurope/Latest+News/Charity-makes-three-research-awards/ArticleStandard/Article/detail/591768?contextCategoryId=43273&ref=25 One of the world's leading eye research centres, the UCL Institute of Ophthalmology, has been awarded three PhD studentships worth £280,000 tenable from October 2009. 2009-04-08T04:00:00Z http://www.oteurope.com/ophthalmologytimeseurope/data/articlestandard/ophthalmologytimeseurope/152009/591768null HTML http://www.oteurope.com/ophthalmologytimeseurope/Latest+News/Can-violent-games-improve-lazy-eyes/ArticleStandard/Article/detail/591767?contextCategoryId=43273&ref=25 Scientists at New York's Rochester University say that playing violent video games may improve contrast sensitivity, which is often impaired by amblyopia. 2009-04-08T04:00:00Z http://www.oteurope.com/ophthalmologytimeseurope/data/articlestandard/ophthalmologytimeseurope/152009/591767null HTML http://www.oteurope.com/ophthalmologytimeseurope/Latest+News/Misidentification-of-retinal-stem-cells/ArticleStandard/Article/detail/591773?contextCategoryId=43273&ref=25 Ciliary epithelial cells inside the eye, previously proposed as retinal cell stems, have now been established as being normal adult cells. The misidentification was uncovered by Michael Dyer, PhD and researchers at the St Jude Department of Developmental Neurobiology. 2009-04-08T04:00:00Z http://www.oteurope.com/ophthalmologytimeseurope/data/articlestandard/ophthalmologytimeseurope/152009/591773null HTML http://www.oteurope.com/ophthalmologytimeseurope/Latest+News/Ground-breaking-method-for-corneal-transplantation/ArticleStandard/Article/detail/591772?contextCategoryId=43273&ref=25 A new method for corneal transplantation developed by Dr Cesar Carriazo, Centro Oftalmológico Carriazo, Colombia was presented at the recent ASCRS 2009 in San Francisco. 2009-04-08T04:00:00Z http://www.oteurope.com/ophthalmologytimeseurope/data/articlestandard/ophthalmologytimeseurope/152009/591772null HTML http://www.oteurope.com/ophthalmologytimeseurope/Latest+News/Latest-predictive-factor-for-glaucoma/ArticleStandard/Article/detail/589866?contextCategoryId=43273&ref=25 Quantitative analysis of colour vision defects provides the possibility of follow-up and may be a useful means for detecting early glaucomatous changes in patients with normal visual fields. 2009-04-01T04:00:00Z http://www.oteurope.com/ophthalmologytimeseurope/data/articlestandard/ophthalmologytimeseurope/142009/589866null HTML http://www.oteurope.com/ophthalmologytimeseurope/Latest+News/Lifetime-achievement-award-for-geneticist/ArticleStandard/Article/detail/589871?contextCategoryId=43273&ref=25 The founder of a public database that helps ophthalmologists and other members of the medical profession is the recipient of the 2009 March of Dimes/Colonel Harland Sanders Award for lifetime achievement in the field of genetic sciences. 2009-04-01T04:00:00Z http://www.oteurope.com/ophthalmologytimeseurope/data/articlestandard/ophthalmologytimeseurope/142009/589871null HTML http://www.oteurope.com/ophthalmologytimeseurope/Latest+News/Advantages-of-aspheric-aberration-free-method/ArticleStandard/Article/detail/589867?contextCategoryId=43273&ref=25 Patients in need of visual corrections whose vision is not affected by existing high-order aberrations (HOAs) may have an alternative to wavefront treatment using an aberration-free method. 2009-04-01T04:00:00Z http://www.oteurope.com/ophthalmologytimeseurope/data/articlestandard/ophthalmologytimeseurope/142009/589867null HTML http://www.oteurope.com/ophthalmologytimeseurope/Latest+News/Zebrafish-help-us-understand-retinal-diseases/ArticleStandard/Article/detail/589870?contextCategoryId=43273&ref=25 Biologists at the Florida State University, USA, have discovered a gene mutation in Zebrafish that determines if the cells develop as rods or as cones. 2009-04-01T04:00:00Z http://www.oteurope.com/ophthalmologytimeseurope/data/articlestandard/ophthalmologytimeseurope/142009/589870null HTML http://www.oteurope.com/ophthalmologytimeseurope/Latest+News/Glaucoma-link-to-different-gene-variations/ArticleStandard/Article/detail/589868?contextCategoryId=43273&ref=25 While researching the long-suspected gene linked to glaucoma, WDR36, Michael Walter, PhD, and team discovered that the gene STL1 is only one of many other genes in which mutations must take place in order for WDR36 to cause glaucoma. 2009-04-01T04:00:00Z http://www.oteurope.com/ophthalmologytimeseurope/data/articlestandard/ophthalmologytimeseurope/142009/589868null HTML http://www.oteurope.com/ophthalmologytimeseurope/Latest+News/Prosthetic-implants-to-oxygenate-retinal-tissue/ArticleStandard/Article/detail/589869?contextCategoryId=43273&ref=25 Blindness in millions of people with diseases that starve eye tissue and nerves of oxygen might be averted with a procedure being developed by researchers at Oak Ridge National Laboratory, the University of Southern California and the University of Tennessee. 2009-04-01T04:00:00Z http://www.oteurope.com/ophthalmologytimeseurope/data/articlestandard/ophthalmologytimeseurope/142009/589869null HTML http://www.oteurope.com/ophthalmologytimeseurope/Retina+news/Link-between-ROP-and-haemangioma-in-low-birth-weig/ArticleStandard/Article/detail/588585?contextCategoryId=43273&ref=25 In infants with birth weights of 1250 g, haemangiomas are associated with the development of retinopathy of prematurity (ROP), according to study data published in the March 2009 issue of Pediatrics. 2009-03-25T04:00:00Z http://www.oteurope.com/ophthalmologytimeseurope/data/articlestandard/ophthalmologytimeseurope/132009/588585null HTML http://www.oteurope.com/ophthalmologytimeseurope/Retina+news/Red-meat-consumption-associated-with-early-AMD/ArticleStandard/Article/detail/588588?contextCategoryId=43273&ref=25 According to Eye Research Australia researchers at the University of Melbourne, a high intake of fresh and processed red meat is positively associated with early AMD, the leading cause of blindness among older people. Diet has often been postulated to alter the risk of AMD. 2009-03-25T04:00:00Z http://www.oteurope.com/ophthalmologytimeseurope/data/articlestandard/ophthalmologytimeseurope/132009/588588null HTML http://www.oteurope.com/ophthalmologytimeseurope/Cornea/Patient-enrolment-completed-for-prevention-of-corn/ArticleStandard/Article/detail/588590?contextCategoryId=43273&ref=25 Lux Biosciences has just completed its enrolment in the company's Phase III LUCIDA (LUx Corneal Transplant Implant Development and Advancement of Therapy) clinical trial programme for LUMITECT (LX201), a silicone matrix ocular (episcleral) implant designed to provide the continuous release for one year of therapeutic levels of cyclosporine A locally to the eye to prevent corneal transplant rejection. 2009-03-25T04:00:00Z http://www.oteurope.com/ophthalmologytimeseurope/data/articlestandard/ophthalmologytimeseurope/132009/588590null HTML http://www.oteurope.com/ophthalmologytimeseurope/CatRef+news/Managing-post-PRK-discomfort/ArticleStandard/Article/detail/588586?contextCategoryId=43273&ref=25 When treating post-phacorefractive keratectomy (PRK) discomfort, there are no significant differences in either safety or efficacy between bromfenac twice-daily and ketorolac four times daily, according to a study published in the February issue of the Journal of Refractive Surgery. 2009-03-25T04:00:00Z http://www.oteurope.com/ophthalmologytimeseurope/data/articlestandard/ophthalmologytimeseurope/132009/588586null HTML http://www.oteurope.com/ophthalmologytimeseurope/Ophthalmology+product+news/Novagali-technologies-allow-greater-drug-access-to/ArticleStandard/Article/detail/588584?contextCategoryId=43273&ref=25 According to research analysts it is estimated that as little as five percent of a topically applied drug ever reaches the intraocular tissues due to drug loss as the result of tearing, lacrimal fluid-eye barriers, and blood-ocular barriers. 2009-03-25T04:00:00Z http://www.oteurope.com/ophthalmologytimeseurope/data/articlestandard/ophthalmologytimeseurope/132009/588584null HTML http://www.oteurope.com/ophthalmologytimeseurope/Dry+Eye/Testing-dry-eye-diagnostic-system/ArticleStandard/Article/detail/587346?contextCategoryId=43273&ref=25 The TearLab Osmolarity Core Validation Study, a multicentre international clinical study assessing the efficacy of the TearLab Osmolarity System for the diagnosis of dry eye disease, has been launched by the system's maker, OccuLogix Inc, and sponsored by Alcon. 2009-03-18T04:00:00Z http://www.oteurope.com/ophthalmologytimeseurope/data/articlestandard/ophthalmologytimeseurope/122009/587346null HTML http://www.oteurope.com/ophthalmologytimeseurope/Infection+%26+Inflammation/Retisert-implant-in-sympathetic-ophthalmia/ArticleStandard/Article/detail/587351?contextCategoryId=43273&ref=25 The fluocinolone acetonide (Retisert; Bausch & Lomb) surgical implant can prevent blindness in cases of sympathetic ophthalmia (SO), according to research at the University of Iowa, US. 2009-03-18T04:00:00Z http://www.oteurope.com/ophthalmologytimeseurope/data/articlestandard/ophthalmologytimeseurope/122009/587351null HTML http://www.oteurope.com/ophthalmologytimeseurope/Refractive+clinical/Perfecting-refractive-surgery-with-eye-drops/ArticleStandard/Article/detail/587355?contextCategoryId=43273&ref=25 Although refractive procedures are wide-ranging — from refractive laser surgery all the way through to cataract surgery with intraocular lens (IOL) implantation — the sensation of dry eye is common to all. 2009-03-18T04:00:00Z http://www.oteurope.com/ophthalmologytimeseurope/data/articlestandard/ophthalmologytimeseurope/122009/587355null HTML http://www.oteurope.com/ophthalmologytimeseurope/Ophthalmology+research+news/Link-between-skin-cancer-and-eye-cancer/ArticleStandard/Article/detail/585411?contextCategoryId=43273&ref=25 There is an association between uveal and a variety of skin melanomas, according to study results published in the March issue of Ophthalmology. 2009-03-11T04:00:00Z http://www.oteurope.com/ophthalmologytimeseurope/data/articlestandard/ophthalmologytimeseurope/102009/585411null HTML http://www.oteurope.com/ophthalmologytimeseurope/Latest+News/Uveitis-study-enters-Phase-IIa/ArticleStandard/Article/detail/583735?contextCategoryId=43273&ref=25 ESBATech AG, a developer of antibody fragment therapeutics, has initiated a Phase IIa study in patients with acute anterior uveitis, designed to evaluate the safety, tolerability and clinical activity of topically applied ESBA105. 2009-03-04T05:00:00Z http://www.oteurope.com/ophthalmologytimeseurope/data/articlestandard/ophthalmologytimeseurope/092009/583735null HTML http://www.oteurope.com/ophthalmologytimeseurope/Latest+News/GSK-and-UCL-team-up/ArticleStandard/Article/detail/583842?contextCategoryId=43273&ref=25 GlaxoSmithKline (GSK) and University College London's Institute of Ophthalmology have agreed a deal in which the Institute will investigate the potential of compounds provided by GSK's ophthalmic unit, Ophthiris. 2009-03-04T05:00:00Z http://www.oteurope.com/ophthalmologytimeseurope/data/articlestandard/ophthalmologytimeseurope/092009/583842null HTML http://www.oteurope.com/ophthalmologytimeseurope/Refractive+news/Building-artificial-corneas/ArticleStandard/Article/detail/582721?contextCategoryId=43273&ref=25 Insights gained from research into keratoconus using extremely intense x-rays could refine laser surgeries, including LASIK, and may one day even lead to the development of an artificial cornea, according to researchers at Cardiff University, UK. 2009-02-25T05:00:00Z http://www.oteurope.com/ophthalmologytimeseurope/data/articlestandard/ophthalmologytimeseurope/082009/582721null HTML http://www.oteurope.com/ophthalmologytimeseurope/CatRef+news/Causes-of-infectious-scleritis/ArticleStandard/Article/detail/581664?contextCategoryId=43273&ref=25 Fungus and microbial infection are the most common causes of infectious scleritis, according to study conclusions published in the February issue of Eye. 2009-02-18T05:00:00Z http://www.oteurope.com/ophthalmologytimeseurope/data/articlestandard/ophthalmologytimeseurope/082009/581664null HTML http://www.oteurope.com/ophthalmologytimeseurope/Retina+news/Antioxidants-preserve-vision-in-retina-disease/ArticleStandard/Article/detail/581663?contextCategoryId=43273&ref=25 Consumption of antioxidants may enable retinal degeneration patients to preserve vision even while vascular abnormalities continue to exist, concluded a study published online ahead of print by the Journal of Clinical Investigation. 2009-02-18T05:00:00Z http://www.oteurope.com/ophthalmologytimeseurope/data/articlestandard/ophthalmologytimeseurope/082009/581663null HTML http://www.oteurope.com/ophthalmologytimeseurope/Glaucoma+news/Accuracy-of-IOP-measurements/ArticleStandard/Article/detail/581661?contextCategoryId=43273&ref=25 Dynamic contour tonometry (DCT) may be more accurate than Goldmann applanation tonometry (GAT) in measuring intraocular pressure (IOP), according to study results published in the February issue of Eye. 2009-02-18T05:00:00Z http://www.oteurope.com/ophthalmologytimeseurope/data/articlestandard/ophthalmologytimeseurope/082009/581661null HTML http://www.oteurope.com/ophthalmologytimeseurope/Refractive+news/Nystagmus-and-neck-movement/ArticleStandard/Article/detail/581660?contextCategoryId=43273&ref=25 Patients with nystagmus who posture their head to compensate for the condition tend to suffer restricted neck movements, concluded a study published in the February issue of Eye. 2009-02-18T05:00:00Z http://www.oteurope.com/ophthalmologytimeseurope/data/articlestandard/ophthalmologytimeseurope/082009/581660null HTML http://www.oteurope.com/ophthalmologytimeseurope/Latest+News/Other-ways-to-assess-RP/ArticleStandard/Article/detail/581659?contextCategoryId=43273&ref=25 Metrics other than visual acuity (VA) and visual field (VF) may be useful for assessing retinitis pigmentosa (RP), according to study results published in the February issue of Eye. 2009-02-18T05:00:00Z http://www.oteurope.com/ophthalmologytimeseurope/data/articlestandard/ophthalmologytimeseurope/082009/581659null HTML http://www.oteurope.com/ophthalmologytimeseurope/Refractive+news/Stem-cells-improve-PRK/ArticleStandard/Article/detail/580355?contextCategoryId=43273&ref=25 Human corneal epithelial cells, grown in the lab, are being used in preclinical trials, evaluating if it is possible to enhance the photorefractive keratectomy (PRK) procedure, according to a statement from the trial organizer, International Stem Cell Corporation (ISCO). 2009-02-11T05:00:00Z http://www.oteurope.com/ophthalmologytimeseurope/data/articlestandard/ophthalmologytimeseurope/072009/580355null HTML http://www.oteurope.com/ophthalmologytimeseurope/Retina+news/Phaco-does-not-boost-AMD-progression/ArticleStandard/Article/detail/580357?contextCategoryId=43273&ref=25 No clear link between cataract surgery and progressive age-related macular degeneration (AMD) could be established by a study published in the February issue of Ophthalmology. 2009-02-11T05:00:00Z http://www.oteurope.com/ophthalmologytimeseurope/data/articlestandard/ophthalmologytimeseurope/072009/580357null HTML http://www.oteurope.com/ophthalmologytimeseurope/Retina+news/Sutureless-vitrectomy-and-endophthalmitis-link-fou/ArticleStandard/Article/detail/580361?contextCategoryId=43273&ref=25 Incisions made during sutureless vitrectomy may allow the entry of ocular surface fluid soon after surgery, according to study results published in the February 2009 issue of the American Journal of Ophthalmology. 2009-02-11T05:00:00Z http://www.oteurope.com/ophthalmologytimeseurope/data/articlestandard/ophthalmologytimeseurope/072009/580361null HTML http://www.oteurope.com/ophthalmologytimeseurope/Retina+news/Successful-macular-hole-closure/ArticleStandard/Article/detail/580360?contextCategoryId=43273&ref=25 It is not necessary for patients to remain face-down for more than 24 hours to ensure successful macular hole closure, according to study results published online ahead of print by the British Journal of Ophthalmology. 2009-02-11T05:00:00Z http://www.oteurope.com/ophthalmologytimeseurope/data/articlestandard/ophthalmologytimeseurope/072009/580360null HTML http://www.oteurope.com/ophthalmologytimeseurope/Glaucoma+news/Carbon-monoxide-lowers-IOP/ArticleStandard/Article/detail/578722?contextCategoryId=43273&ref=25 CORM-3, a water-soluble carbon monoxide-releasing molecule, is associated with a intraocular pressure (IOP) lowering in animal models of ocular hypertension, concluded a study published in the January issue of the British Journal of Ophthalmology. 2009-02-04T05:00:00Z http://www.oteurope.com/ophthalmologytimeseurope/data/articlestandard/ophthalmologytimeseurope/062009/578722null HTML http://www.oteurope.com/ophthalmologytimeseurope/Retina+news/VEGF-Trap-Eye-active-against-DME/ArticleStandard/Article/detail/578724?contextCategoryId=43273&ref=25 A single intravitreal injection of 4.0 mg vascular endothelial growth factor (VEGF) Trap-Eye is associated with bioactivity against diabetic macular oedema (DME), according to study results published in the January issue of the British Journal of Ophthalmology. 2009-02-04T05:00:00Z http://www.oteurope.com/ophthalmologytimeseurope/data/articlestandard/ophthalmologytimeseurope/062009/578724null HTML http://www.oteurope.com/ophthalmologytimeseurope/Cataract+News/Treating-uveitis-with-phaco/ArticleStandard/Article/detail/577234?contextCategoryId=43273&ref=25 Phacoemulsification can increase visual acuity in uveitis patients, concluded a study published in the January issue of the British Journal of Ophthalmology. 2009-01-28T05:00:00Z http://www.oteurope.com/ophthalmologytimeseurope/data/articlestandard/ophthalmologytimeseurope/042009/577234null HTML http://www.oteurope.com/ophthalmologytimeseurope/Cornea/Obtaining-optimum-corneal-tissue-for-transplant/ArticleStandard/Article/detail/577230?contextCategoryId=43273&ref=25 A team in the Philippines has defined criteria that need to be met in order to obtain an optimum tissue quality for corneal grafts. 2009-01-28T05:00:00Z http://www.oteurope.com/ophthalmologytimeseurope/data/articlestandard/ophthalmologytimeseurope/042009/577230null HTML http://www.oteurope.com/ophthalmologytimeseurope/Cataract+News/Blood-thinners-increase-perioperative-complication/ArticleStandard/Article/detail/576013?contextCategoryId=43273&ref=25 Use of warfarin or clopidogrel is associated with a significant increase in non-sight-threatening complications during cataract surgery, concluded a study published in the January issue of Eye. 2009-01-21T05:00:00Z http://www.oteurope.com/ophthalmologytimeseurope/data/articlestandard/ophthalmologytimeseurope/042009/576013null HTML http://www.oteurope.com/ophthalmologytimeseurope/Latest+News/Mobile-phones-do-not-cause-eye-cancer/ArticleStandard/Article/detail/576016?contextCategoryId=43273&ref=25 The use of mobile telephones does not increase the risk of uveal melanoma, according to a study published online ahead of print by the Journal of the National Cancer Institute. 2009-01-21T05:00:00Z http://www.oteurope.com/ophthalmologytimeseurope/data/articlestandard/ophthalmologytimeseurope/042009/576016null HTML http://www.oteurope.com/ophthalmologytimeseurope/Glaucoma+news/Controlling-IOP-with-SLT-and-latanoprost/ArticleStandard/Article/detail/574826?contextCategoryId=43273&ref=25 Both selective laser trabeculoplasty (SLT) and latanoprost are effective at controlling the level and fluctuation of intraocular pressure (IOP), according to a study published online ahead of print by the British Journal of Ophthalmology. 2009-01-14T05:00:00Z http://www.oteurope.com/ophthalmologytimeseurope/data/articlestandard/ophthalmologytimeseurope/032009/574826null HTML http://www.oteurope.com/ophthalmologytimeseurope/Cataract+News/The-impact-of-fungal-endophthalmitis/ArticleStandard/Article/detail/574872?contextCategoryId=43273&ref=25 A great variety of fungal agents may cause endophthalmitis, and accurate diagnosis is essential for effective treatment, according to a study published in the November/December 2008 issue of Retina. 2009-01-14T05:00:00Z http://www.oteurope.com/ophthalmologytimeseurope/data/articlestandard/ophthalmologytimeseurope/032009/574872null HTML http://www.oteurope.com/ophthalmologytimeseurope/Glaucoma+news/Treating-paediatric-glaucoma/ArticleStandard/Article/detail/574869?contextCategoryId=43273&ref=25 Penetrating deep sclerectomy (combining deep sclerectomy with trabeculectomy) delivers promising intermediate results in the treatment of paediatric glaucoma, according to the conclusions of a study published in the January issue of Ophthalmology. 2009-01-14T05:00:00Z http://www.oteurope.com/ophthalmologytimeseurope/data/articlestandard/ophthalmologytimeseurope/032009/574869null HTML http://www.oteurope.com/ophthalmologytimeseurope/Cataract+News/Astigmatism-in-cataract-patients/ArticleStandard/Article/detail/574823?contextCategoryId=43273&ref=25 Most candidates for cataract surgery have a degree of corneal astigmatism, which should be considered by intraocular lens (IOL) manufacturers, concluded a study published in the January issue of the Journal of Cataract & Refractive Surgery. 2009-01-14T05:00:00Z http://www.oteurope.com/ophthalmologytimeseurope/data/articlestandard/ophthalmologytimeseurope/032009/574823null HTML http://www.oteurope.com/ophthalmologytimeseurope/Retina+news/Successful-macular-hole-surgery/ArticleStandard/Article/detail/574874?contextCategoryId=43273&ref=25 Fixation stability influences the visual outcome following macular hole surgery, according to study results published in the January issue of Investigative Ophthalmology and Visual Science. 2009-01-14T05:00:00Z http://www.oteurope.com/ophthalmologytimeseurope/data/articlestandard/ophthalmologytimeseurope/032009/574874null HTML http://www.oteurope.com/ophthalmologytimeseurope/Cataract+News/Reducing-phaco-induced-apoptosis/ArticleStandard/Article/detail/574866?contextCategoryId=43273&ref=25 Cell apoptosis caused by free-radical formation during phacoemulsification can be mediated by the introduction of ascorbic acid, according to a study published in the December 2008 issue of the Journal of Cataract & Refractive Surgery. 2009-01-14T05:00:00Z http://www.oteurope.com/ophthalmologytimeseurope/data/articlestandard/ophthalmologytimeseurope/032009/574866null HTML http://www.oteurope.com/ophthalmologytimeseurope/Retina+news/The-role-of-inflammation-in-DME/ArticleStandard/Article/detail/574821?contextCategoryId=43273&ref=25 The level of various inflammatory factors in the vitreous fluid is a significant factor in the severity of diabetic macular oedema (DME), according to study results published in the January issue of Ophthalmology. 2009-01-14T05:00:00Z http://www.oteurope.com/ophthalmologytimeseurope/data/articlestandard/ophthalmologytimeseurope/032009/574821null HTML http://www.oteurope.com/ophthalmologytimeseurope/Refractive+news/Long-term-treatment-of-strabismus-with-Botox/ArticleStandard/Article/detail/573815?contextCategoryId=43273&ref=25 A long-term course of injections of botulinum toxin ("Botox") offers a viable treatment for complicated strabismus, according to study results published in the December 2008 issue of the Journal of the American Association for Pediatric Ophthalmology and Strabismus. 2009-01-08T05:00:00Z http://www.oteurope.com/ophthalmologytimeseurope/data/articlestandard/ophthalmologytimeseurope/022009/573815null HTML http://www.oteurope.com/ophthalmologytimeseurope/Retina+news/Cryotherapy-reduces-accommodation/ArticleStandard/Article/detail/573879?contextCategoryId=43273&ref=25 Eyes treated with peripheral retinal cryotherapy lose accommodative amplitude after surgery, according to results of a study published in the January 2009 issue of the American Journal of Ophthalmology. 2009-01-08T05:00:00Z http://www.oteurope.com/ophthalmologytimeseurope/data/articlestandard/ophthalmologytimeseurope/022009/573879null HTML http://www.oteurope.com/ophthalmologytimeseurope/Glaucoma+news/Calculating-risk-in-glaucoma/ArticleStandard/Article/detail/573914?contextCategoryId=43273&ref=25 Using a risk calculator might impact ocular hypertension treatment options, concluded a study published in the December 2008 issue of the Journal of Ophthalmology. 2009-01-08T05:00:00Z http://www.oteurope.com/ophthalmologytimeseurope/data/articlestandard/ophthalmologytimeseurope/022009/573914null HTML